AnifrolumabGSDMD inhibitorFcrRIII blocking antibodySLElupus disease
…I blocking antibody, and an FDA-approved IFN receptor blockade (Anifrolumab) attenuated the pathological change in mitochondria triggered b…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: FcrRIII blocking antibody ×
FcrRIII blocking antibody
This drug is selected. Its supporting articles are shown below.